Couverture de Episode 1: Nigeria Beyond Gavi's Immunization Financing Support

Episode 1: Nigeria Beyond Gavi's Immunization Financing Support

Episode 1: Nigeria Beyond Gavi's Immunization Financing Support

Écouter gratuitement

Voir les détails

À propos de cette écoute

Nigeria, Africa's most populous nation, confronts a staggering $200 million annual immunization financing gap and over 2.2 million Zero-Dose Children. As the country prepares for its transition away from Gavi support by 2028, securing sustainable financing for vaccines is paramount for public health.

In this inaugural episode of the "One Shot, Long Life!" podcast by GHAI, host Abel Akara Ticha dives deep into Nigeria's challenges and opportunities with leading vaccine advocacy champions: Chika Offor (CEO, Vaccine Network for Disease Control) and Prof. Emmanuel Alhassan (GHAI Country Coordinator, Nigeria).

Discover the barriers hindering domestic funding for immunization, including fiscal constraints and competing priorities. Learn about innovative strategies being pursued, such as establishing a first-line charge mechanism for the health budget and kickstarting local vaccine production. Explore the vital role of CSO advocacy and budget advocacy in pushing for increased vaccine coverage, strengthening health systems, integrating immunization into primary healthcare (PHC) services, and achieving vaccine equity.

Join us to understand the critical steps Nigeria is taking – and still needs to take – towards closing the immunization funding gap and ensuring a healthy future for every child. This episode explores the economic impact of immunization programs and the ongoing fight for health equity in Nigeria.

Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !

    Ce que les auditeurs disent de Episode 1: Nigeria Beyond Gavi's Immunization Financing Support

    Moyenne des évaluations utilisateurs. Seuls les utilisateurs ayant écouté le titre peuvent laisser une évaluation.

    Commentaires - Veuillez sélectionner les onglets ci-dessous pour changer la provenance des commentaires.

    Il n'y a pas encore de critique disponible pour ce titre.